Opioid drug giant Mallinckrodt, selling more than Purdue Pharma in the United States, has been forced by the courts to publish more than 1.3 million internal documents. These reveal a carefully coordinated effort to shape medical attitudes toward pain medicine.
United States Supreme Court Gives Pharma Companies a Chance to Thwart Terrorism-Funding Lawsuit